119302-24-8,
(2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane,
2beta-(4-Morpholinyl)-16beta-(1-pyrrolidinyl)-5alpha-androstane-3alpha,17beta-diol 17-acetate,
YBZSVMDKHBRYNB-RIQJFVKASA-N,
SCHEMBL1036319,
CTK0H4940,
C29H48N2O4,
Rocuronium bromide intermediate VIII,
ANW-53097,
CR0017,
MFCD09833552,
ZINC59769910,
AKOS015966774,
AC-5927,
cyclopenta[a]phenanthren-17-yl acetate,
AN-10475,
BC651839,
DS-15502,
O155,
AX8030449,
ST2414209,
TC-141842,
Rocuronium Related Compound A (EP impurity A),
302A248,
Q-101013,
(2,3,5,16,17)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane,
(2|A,3|A,5|A,16|A,17|A)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane,
(2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane,
(2beta,3alpha,5alpha,16beta,17beta)-2-(4-morpholinyl)-16(1-pyrrolidinyl)-androstane-3,17-diol 17-acetate,
(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholino-16-(pyrrolidin-1-yl)hexadecahydro-1H-,
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholino-16-pyrrolidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate,
2beta-(4-morpholinyl)-16beta-(1-pyrrolidinyl)-5alpha-androstan-3alpha,17beta-diol 17-acetate,
Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-,
ACN-048350,
EC 601-596-0,
(2|A,3|A,5|A,16|A,17|A)-17-Acetoxy-3-hydroxy-2-(4-,
3?-Hydroxy-2?-(morpholin-4-yl)-16?-(pyrrolidin-1-yl)-5?-androstan-17?-yl acetate,
(2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane(9ci),
Androstan-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, 17-acetate (2alpha,3alpha,5alpha,16alpha,17beta)-,